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S8 Diabetic NephropathyQDPR promoter might be a potential target of TSF in treating DN. TSF’s drug
target may located between 529 and 250 promoter fragment.http://dx.doi.org/10.1016/j.hkjn.2015.08.026
0098
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Peroxisome Proliferator Activated Receptor Gamma Gene with Diabetic
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Objective: To evaluate the association of Pro12Ala polymorphism of Perox-
isome Proliferator Activated Receptor-gamma2 (PPARg2) gene with (diabetic
kidney disease, DKD) in Chinese Han population.
Methods: The present investigation was carried out using the keywords “dia-
betic kidney disease”, “DKD”, “diabetic nephropathy”, “DN”, “peroxisome
proliferator-activated receptor-gamma 2”, “PPARg2”, “polymorphism” and
“Prol2Ala”. PubMed. Chinese Biomedicine Database (CBM). China National
Knowledge Infrastructure (CNKI). Wanfang and VIP database were searched
for all relevant articles investigating the association between PPARg2
Pro12Ala polymorphism and DKD that were available. The odds ratios (OS)
for Alal2 used as the metric of choice were calculated in the dominant
and additive model separately. The Meta-analysis was conducted by softe-
ware Stata12.0.
Results: We identified 8 studies, involving 1439 DKD cases and 913 controls
fell into the inclusion criteria. The analysis indicated no significant inter-
study heterogeneity and publication bias. There was no heterogeneity
(PBegg, PEgger > 0.05) among the 8 qualified articles. The pooled OR (95%
CI) value of the frequencies of the PPARg2 genotype (PA+AA)/PP calculated
by fixed-effects model was 0.55 (0.34e0.71) (P < 0.05). A/P calculated by
fixed-effects model was 0.57 (0.45e0.73) (P < 0.05).
Conclusion: In this meta-analysis, the Prol2Ala gene variant (rsl801282) is
found to be associated with the susceptibility for DKD in Chinese Han
population.http://dx.doi.org/10.1016/j.hkjn.2015.08.027
0099
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Objective: To evaluate the effectiveness and safety of Pro12Ala polymor-
phism of traditional Chinese medicine on diabetic kidney disease with
dyslipidemias.
Methods: All randomized or semi-randomized controlled trials (RCTs or semi-
RCTs) of traditional Chinese medicine in treating diabetic kidney disease
with dyslipidemias were collected from PubMed, Cochrane library, Chinese
Biomedicine Database (CBM), China National Knowledge Infrastructure
(CNKI). Wanfang and VIP database. After two researchers for screening
and data extraction independently, the quality of the included literature
research was evaluated according to the Cochrane risk of bias, then Revman
5.3 was used to undertake meta-analysis.
Results: We identified 8 studies, involving 449 patients. Experimental group
237 patients vs control group 212 patients. Meta analysis indicated that
traditional Chinese medicine treatment gave better results in lowering
serum total cholesterol (TC) [MD Z 1.21, 95%CI (1.75, 0.66)], total tri-
glyceride(TG) [MD Z 0.89, 95% CI (1.26, 0.52)]. But there is nostatistically significant for lowering high density lipoprotein cholesterol
(HDL-C) [MD Z 0.34, 95% CI (0.09, 0.77)] compared with control ther-
apy alone.
Conclusion: Traditional Chinese medicine significantly reduced TC, TG, and
improved total efficiency of the symptoms and signs in diabetic kidney dis-
ease with dyslipidemias.http://dx.doi.org/10.1016/j.hkjn.2015.08.028
0102
Transcription Factor SRF Promotes Renal Fibrosis in Diabetic
Nephropathy
lijie He, Shiren Sun, Jinping Hu, Ning Feng, Tiantian Shi
Department of Nephrology, Xi’an, China
Background: The role of transcription factors SRF, which regulate CArG
element contained genes, in diabetic nephropathy is unknown.
Methods: Here we performed expression of SRF in human diabetic nephrop-
athy tissues and the cultured proximal tubular cells (HK-2) under high-
glucose or induced by TGF-bcompared with control conditions.
Results: We identified overexpression of SRF was observed in glucose-
induced HK-2 cells. Next, we performed SRF expression from formalin-fixed,
paraffin-embedded tissues from renal biopsies diagnosis as diabetic ne-
phropathy. We noted the greatest change in SRF expression, which was
significantly higher in late presenters compared with early presenters.
Furthermore, in individual biopsies, high expression of SRF correlated with
tubulointerstitial fibrosis and low estimated GFR. In vitro, treatment of
HK-2 with TGF-b increased SRF expression. Lower expression of SRF sup-
pressed expression of the CArG element snail1, thereby opposing TGF-b-
mediated downregulation of E-cadherin.
Conclusion: High expression of SRF associates with increased fibrosis and
decreased estimated GFR in diabetic nephropathy in vivo, perhaps by
enhancing TGF-b-mediated downregulation of snail in HK-2.http://dx.doi.org/10.1016/j.hkjn.2015.08.029
0123
Ginsenoside Rg1 Attenuates Autophagy Triggered by Angiotensin II
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Objectives: Angiotensin II (AngII) is an important effecter of the renal RAS
cascade and plays multiple roles in kidney disease. It has been reported
that AngII can cause podocyte injury by increasing intracellular calcium
influx. In this study, we test whether AngII can induce autophagy of podocyte
and the potential protective role of ginsenoside Rg1 in this process.
Methods: MPC5 cells (mouse podocyte cell line) were cultured with AngII and
the autophagy level was assessed by intracellular autophagosome number,
conversion of LC3-I to LC3-II and expression of Beclin-1. The intracellular
reactive oxygen species (ROS) level was determined by 2,7-dichlorofluores-
cin diacetate (DCFH-DA) assay. To investigate the protective role of ginseno-
side Rg1, MPC5 cells were pre-treated with ginsenoside Rg1 followed by AngII
stimulation. Western blot was employed to determine the phosphorylation
status of AMPK and P70S6K.
Results: Increased autophagy was observed in MPC5 cells stimulated by Ang
II as indicated by increased number of autophagosome, LC3-I to LC3-II
